Jasmohan Bajaj's Avatar

Jasmohan Bajaj

@jasmohanbajaj.bsky.social

Liver specialist at Virginia Commonwealth University and Richmond VAMC . Interested in the brain liver gut axis. Co-EIC of Am J Gastro. Posts are personal.

792 Followers  |  388 Following  |  11 Posts  |  Joined: 12.11.2024  |  1.9807

Latest posts by jasmohanbajaj.bsky.social on Bluesky

Post image

Refinement of Hy Law Using the Drug-Induced Liver Injury Network Database
Barritt, et al.

πŸ“• bit.ly/4kQDarW

20.06.2025 11:00 β€” πŸ‘ 2    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

It's finally here! Consensus #ACLF & #cirrhosis organ failure definitions. ‡️
pubmed.ncbi.nlm.nih.gov/40499736/
Why? We need to speak the same language re #ACLF
How? Multi-country consensus panels
Result? Harmonized definitions & Β research agenda @aasldnews.bsky.social @easlnews.bsky.social

16.06.2025 18:16 β€” πŸ‘ 0    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Amazing panel discussions at the end of the EASL-ESCMID session at #EASLCongress 2025

#AMR, #liver, #cirrhosis

@easlnews.bsky.social
@escmid.bsky.social
@esgvh.bsky.social
@oana-sandulescu.bsky.social
@jasmohanbajaj.bsky.social

10.05.2025 09:15 β€” πŸ‘ 4    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

In the #RedJournal:

Supplement β€” Demystifying Carbohydrate Maldigestion: A Clinical Review
Brooks D. Cash, MD, FACG; Daksesh Patel, DO & Kate Scarlata, MPH, RDN

πŸ“• bit.ly/3GhUN4q
@katescarlata.bsky.social @jasmohanbajaj.bsky.social

20.04.2025 13:00 β€” πŸ‘ 3    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Explore the April issue of the #RedJournal!

Featuring the new ⭐ ACG Guideline on Gastric Premalignant Conditions and ⭐ US Multi-Society Task Force on CRC consensus recommendations on bowel prep for colonoscopy.

πŸ“• bit.ly/AmJGastro
@jasmohanbajaj.bsky.social

07.04.2025 11:00 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

In the πŸ“•#RedJournal:

Timing of Direct Oral Anticoagulants Resumption Following Colorectal Endoscopic Submucosal Dissection: A Nationwide Study in Japan
Ichita, et al.

πŸ‘‰ bit.ly/4iRPbvM

24.03.2025 16:00 β€” πŸ‘ 3    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image Post image

Recent study:⬆️ #daptomycin resist w #rifaximin.
But does this impact outcomes in #cirrhosis?
In VA & TriNetX we found no impact of rifaximin on dapt users on
πŸ”‘30-day mortality
πŸ”‘LT
πŸ”‘sepsis dev
πŸ”‘linezolid use
βœ… @amergastroassn.bsky.social ➑️ pubmed.ncbi.nlm.nih.gov/40122471/ @absteward.bsky.social

24.03.2025 13:26 β€” πŸ‘ 4    πŸ” 3    πŸ’¬ 0    πŸ“Œ 1
Post image

In the πŸ“•#RedJournal:

The Red Section: Guidelines in Practice β€” Alcohol-Associated Liver Disease
Loretta L. Jophlin, MD, PhD*; Ashwani K. Singal, MD, MS, FACG* & Vijay H. Shah, MD, FACG

πŸ‘‰ bit.ly/4kPSMwk
@jasmohanbajaj.bsky.social

21.03.2025 20:46 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

In #CTGjournal:

Secondary SBP Prophylaxis is Associated with a Higher Rate of Non-SBP Infections in Two US-based National Cirrhosis Cohorts
Silvey, et al.

➑️ bit.ly/428BEKH
@jasmohanbajaj.bsky.social

15.03.2025 18:23 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Preview
Infections in Standard or Tapered Dose of Prednisolone for... : Official journal of the American College of Gastroenterology | ACG mary objective was to assess the incidence of infection by day 90. The key secondary objectives were the incidence of mortality, acute kidney injury (AKI), readmissions rate and adverse events. Metho...

After five decades, steroid dosing in AAH is revisited: Tapered prednisolone proves superior in reducing infections.
#STASH trial @jasmohanbajaj.bsky.social @juanpabloarab.bsky.social @ebtapper.bsky.social @tonybreu.bsky.social
@blaneymd.medsky.social
journals.lww.com/ajg/abstract... #liversky

13.03.2025 17:12 β€” πŸ‘ 12    πŸ” 7    πŸ’¬ 2    πŸ“Œ 1
Post image Post image Post image Post image

Unnecessary #antibiotics: #SBP prophylaxis in #cirrhosis ⬆️ #SBP & other infections! Esp #UTIs w similar🦠
latest from VA & Trinetx ‡️
pubmed.ncbi.nlm.nih.gov/40062879/
50% of US ❌use SBPProph..should we all follow & ⬇️ #AMR?
@absteward.bsky.social @amcollegegastro.bsky.social @ebtapper.bsky.social

11.03.2025 00:01 β€” πŸ‘ 20    πŸ” 5    πŸ’¬ 3    πŸ“Œ 1
Post image

Explore the March issue of The American Journal of #Gastroenterology!

πŸ“• bit.ly/AmJGastro

@jasmohanbajaj.bsky.social @andrewmmoon.bsky.social

07.03.2025 23:11 β€” πŸ‘ 6    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

Dedicated to #ColorectalCancerScreening!

ACG's Board of Trustees under the leadership of President Dr. @amyoxentenkomd.bsky.social

These visionary leaders ensure ACG aligns its actions & priorities with its mission & vision

#ColorectalCancerAwarenessMonth #DressinBlueDay #ACGfamily #GastroSky

07.03.2025 21:15 β€” πŸ‘ 10    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Thanks #CDDW #CLM Chris Rose & Premsyl Bercik for the invite to speak in a beautiful but freezing Quebec city on #HE #microbes & #gutbrainaxis. Excellent joint session with #microbiology & #gi expertise. πŸ‡¨πŸ‡¦ warmth shone thru despite the polar vortex!! @vculiver.bsky.social

02.03.2025 14:30 β€” πŸ‘ 8    πŸ” 2    πŸ’¬ 2    πŸ“Œ 0
Preview
JCI Insight - Intestinal mucosal mitochondrial oxidative phosphorylation worsens with cirrhosis progression and is ameliorated with FMT Research LetterIn-Press PreviewHepatologyMicrobiology Open Access | 10.1172/jci.insight.186649

ASCI member @jasmohanbajaj.bsky.social et al. show that fecal transplant ameliorates a source of cirrhosis progression.

27.02.2025 16:13 β€” πŸ‘ 1    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image

In the πŸ“•#RedJournal:

Update on Newly Federal Drug Administration-Approved Drug, Resmetirom: A Practical Perspective
A. Sidney Barritt, IV, MD, MSCR, FACG & Jonathan G. Stine, MD, MSc

πŸ‘‰ bit.ly/438oCOq

@sidbarritt4.bsky.social @jonathanstinemd.bsky.social

22.02.2025 16:00 β€” πŸ‘ 3    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Post image

In the πŸ“•#RedJournal:

The Effects of Alfapump on Ascites Control and Quality of Life in Patients With Cirrhosis and Recurrent or Refractory Ascites
Wong, et al.

πŸ‘‰ bit.ly/3QsoPnM
@jasmohanbajaj.bsky.social

21.02.2025 19:52 β€” πŸ‘ 5    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0
Preview
NIH In Your State - United For Medical Research Select a state on the map to see the impact of NIH funding across America.

Please check out this powerful statement re: #NIH by @kerialthoff.bsky.social :

πŸŽ₯: www.instagram.com/reel/DF3kmec...

Then go here to check out the impact for *your* state:

πŸ’°: www.unitedformedicalresearch.org/nih-in-your-...

& Contact your US Sen.s/Rep.!:

☎️ : www.usa.gov/elected-offi...

10.02.2025 02:29 β€” πŸ‘ 18    πŸ” 9    πŸ’¬ 2    πŸ“Œ 0
Preview
A Global Perspective on Metabolically Driven Primary Liver... : Official journal of the American College of Gastroenterology | ACG An abstract is unavailable.

Metabolic risk factors are increasingly important drivers of primary liver cancer but.... it's complicated

Joseph Ahn lays out the power and perils of Global Burden of Disease data in this editorial in @amcollegegastro.bsky.social #AJG editorial

journals.lww.com/ajg/fulltext...

#GISky #LiverSky

10.02.2025 14:07 β€” πŸ‘ 3    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

πŸ™ @paulsaxmd.bsky.social for the invitation to write this from a #liversky and #IDsky perspective @cidjournal.bsky.social
Totally agree the approach needs to shift! @vculiver.bsky.social @idsainfo.bsky.social @easlnews.bsky.social @varesearch.bsky.social

05.02.2025 13:43 β€” πŸ‘ 14    πŸ” 4    πŸ’¬ 1    πŸ“Œ 0
Preview
Rethinking Antibiotic Prophylaxis for Spontaneous Bacterial Peritonitis in Patients with Cirrhosis: First, Do No Harm Abstract. Antibiotic prophylaxis for spontaneous bacterial peritonitis (SBPPr) in patients with cirrhosis has been considered standard of care since the 19

Wait. ONE lousy trial is the major reason for spontaneous bacterial peritonitis prophylaxis?! Thanks to @paulsaxmd.bsky.social for this!

#IDSky #Medsky

academic.oup.com/cid/advance-...

04.02.2025 21:43 β€” πŸ‘ 8    πŸ” 3    πŸ’¬ 1    πŸ“Œ 0
Post image

The February Issue of The American Journal of #Gastroenterology is now available!

Explore this month's articles, including the new joint ACG-@asgeendo.bsky.social Quality Indicators for Upper GI Endoscopy!

πŸ“•bit.ly/AmJGastro
@jasmohanbajaj.bsky.social

04.02.2025 19:43 β€” πŸ‘ 2    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

πŸ™ for highlighting our commentary @cidjournal.bsky.social
Need to re-evaluate these practices due to ⬆️
- #amr burden
- C difficile & #antibiotic adverse events
- costs
#liversky #gisky @varesearch.bsky.social @idsainfo.bsky.social @amcollegegastro.bsky.social @easlnews.bsky.social

03.02.2025 15:53 β€” πŸ‘ 6    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image

ACG is proud to be hosting a summit on AI in GI, covering responsible, practical, and sustainable applications to improve clinical practice and patient outcomes.

Thanks to our many experts and innovators for helping shape the future of AI in our field! #AIinGI #GastroSky

24.01.2025 21:54 β€” πŸ‘ 8    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0
Post image Post image Post image Post image

Pts w #Hepaticencephalopathy get a raw deal for #Livertransplant. Does MELD3.0 help?
πŸ”‘ we need to do more!
In @varesearch.bsky.social #cirrhosis pts @amcollegegastro.bsky.social
πŸ”‘inpt HE adds >4-5 MELD3.0 points for 90D & 6-7 for 1Y mortality
πŸ”‘HE needs priority!‡️
pubmed.ncbi.nlm.nih.gov/39836914/

23.01.2025 03:39 β€” πŸ‘ 9    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1
Post image

Check out @nytimes.com interview of experts re: #wellness my tip? Coffee for the win!! Liver brain and microbes all benefit from this
Check it out below
www.nytimes.com/interactive/... @vculiver.bsky.social @amcollegegastro.bsky.social @ebtapper.bsky.social @easlnews.bsky.social

13.01.2025 16:01 β€” πŸ‘ 16    πŸ” 7    πŸ’¬ 0    πŸ“Œ 1
Post image

❗NEW! #RedJournal Special Issue on πŸ”₯ Inflammation in Digestive Diseases πŸ”₯

From Co-EICs Dr. Jasmohan Bajaj & Dr. Millie Long:
"The 'Red Journal' is on fire this month, to change how you think about inflammation in practice."

πŸ“• bit.ly/AmJGastro

@jasmohanbajaj.bsky.social @andrewmmoon.bsky.social

03.01.2025 18:19 β€” πŸ‘ 11    πŸ” 3    πŸ’¬ 0    πŸ“Œ 1
Post image

NEW! ACG Clinical Guideline:
Management of Eosinophilic Esophagitis #EoE

Dellon, et al.
πŸ“•Read bit.ly/acg-eoe-2025
πŸŽ™οΈListen bit.ly/ajg-podcast-...
πŸ”†Highlights bit.ly/acg-eoe-guid...

#GastroSky #MedSky
@jasmohanbajaj.bsky.social @andrewmmoon.bsky.social @cneumsma.bsky.social

02.01.2025 15:35 β€” πŸ‘ 16    πŸ” 6    πŸ’¬ 0    πŸ“Œ 0
Preview
Clinical Implications of Inflammation in Patients With... : Official journal of the American College of Gastroenterology | ACG state with coexistent severe immune paralysis that defines acute decompensation and acute-on-chronic liver failure. Systemic inflammation plays a crucial role in the disease course of cirrhosis and is...

Delighted to share our recent review in @AmJGastro Clinical Implications of Inflammation in Patients With Cirrhosis journals.lww.com/ajg/fulltext... @jasmohanbajaj.bsky.social

02.01.2025 17:06 β€” πŸ‘ 7    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

πŸ—“οΈSAVE THE DATE! #ACG2025 Annual Scientific Meeting & Postgraduate Course

🌡Phoenix, AZ October 24-29, 2025

Timely and relevant postgraduate course offerings and innovative clinical science in #Gastroenterology #Hepatology and #Endoscopy!

#GastroSky #LiverSky #EndoscopySky

20.12.2024 16:24 β€” πŸ‘ 6    πŸ” 1    πŸ’¬ 0    πŸ“Œ 1

@jasmohanbajaj is following 19 prominent accounts